Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engineering protein and DNA tools for creating DNA-dependent protein switches. | Methods Enzymol | 2022 | 36220266 | PubTator, text mining | PubMed |
| Two type I topoisomerases maintain DNA topology in human mitochondria. | Nucleic Acids Res | 2022 | 36215039 | PubTator, text mining | PubMed |
| Nanoformulation of Tetrapyrroles Derivatives in Photodynamic Therapy: A Focus on Bacteriochlorin. | Evid Based Complement Alternat Med | 2022 | 36212948 | PubTator, text mining | PubMed |
| A double-edged sword: The effects of R&D intensity and capitalization on institutional investment in entrepreneurial firms. | Front Psychol | 2022 | 36211902 | PubTator, text mining | PubMed |
| Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021. | J Hematol Oncol | 2022 | 36209184 | PubTator, text mining | PubMed |
| Molecular basis for processing of topoisomerase 1-triggered DNA damage by Apn2/APE2. | Cell Rep | 2022 | 36198268 | PubTator, text mining | PubMed |
| Enterprise digital transformation and customer concentration: An examination based on dynamic capability theory. | Front Psychol | 2022 | 36186358 | PubTator, text mining | PubMed |
| Revisiting potential value of antitumor drugs in the treatment of COVID-19. | Cell Biosci | 2022 | 36182930 | PubTator, text mining | PubMed |
| Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report. | Medicine (Baltimore) | 2022 | 36181052 | PubTator, text mining | PubMed |
| Ovarian cancer resistance to PARPi and platinum-containing chemotherapy. | Cancer Drug Resist | 2022 | 36176755 | PubTator, text mining | PubMed |
| Topoisomerase 1-dependent R-loop deficiency drives accelerated replication and genomic instability. | Cell Rep | 2022 | 36170822 | PubTator, text mining | PubMed |
| The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. | Theranostics | 2022 | 36168628 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Improving MHC class I antigen-processing predictions using representation learning and cleavage site-specific kernels. | Cell Rep Methods | 2022 | 36160050 | PubTator, text mining | PubMed |
| Protein Succinylation and Malonylation as Potential Biomarkers in Schizophrenia. | J Pers Med | 2022 | 36143193 | PubTator, text mining | PubMed |
| Identification of Human Global, Tissue and Within-Tissue Cell-Specific Stably Expressed Genes at Single-Cell Resolution. | Int J Mol Sci | 2022 | 36142130 | PubTator, text mining | PubMed |
| Placental OLAH Levels Are Altered in Fetal Growth Restriction, Preeclampsia and Models of Placental Dysfunction. | Antioxidants (Basel) | 2022 | 36139751 | PubTator, text mining | PubMed |
| RetroComposer: Composing Templates for Template-Based Retrosynthesis Prediction. | Biomolecules | 2022 | 36139164 | PubTator, text mining | PubMed |
| FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ. | Sci Adv | 2022 | 36129980 | PubTator, text mining | PubMed |
| Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver disease. | Pharm Biol | 2022 | 36124995 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=44